IP Library Granted Patent US 11,946,102
Granted Patent B2
US 11,946,102 · App. 17/064,628 · Granted Apr 2, 2024

Coupling method

Inventors: James Anthony Clarke (Oxford, GB); James White (Oxford, GB); John Milton (Oxford, GB); Clive Gavin Brown (Cambridge, GB)
Assignee: Oxford Nanopore Technologies PLC
C12Q1/6869B82Y15/00G01N27/44743G01N33/48721
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,946,102
App. No.
17/064,628
Granted
Apr 2, 2024
Kind
B2
Abstract

The invention relates to a new method of determining the presence, absence or characteristics of an analyte. The analyte is coupled to a membrane. The invention also relates to nucleic acid sequencing.

Claims (28)

1. A method for detecting analytes, comprising:

(a) providing a membrane in which is present a nanopore that provides a channel through the membrane;

(b) contacting the membrane, in an ionic solution, with one or more analytes, wherein following contact with the membrane the analytes are tethered to the membrane via a tethering group;

(c) applying a potential difference across the membrane and detecting a first analyte using the nanopore, from among the analytes tethered to the membrane; and

(d) detecting a second analyte, from among the analytes tethered to the membrane, using the same nanopore, wherein the second analyte is not the first analyte;

wherein the one or more analytes is an amino acid, peptide, polypeptide, or protein.

2. The method according to claim 1 , wherein the membrane is an amphiphilic layer or a solid state layer.

3. The method according to claim 1 , wherein the membrane is a lipid bilayer.

4. The method according to claim 1 , wherein the tethering group comprises a hydrophobic anchor.

5. The method according to claim 4 , wherein the hydrophobic anchor is capable of embedding in the membrane.

6. The method according to claim 4 , wherein the hydrophobic anchor is a lipid, fatty acid, sterol, carbon nanotube or amino acid.

7. The method according to claim 1 , wherein the tethering group comprises a linker.

8. The method according to claim 7 , wherein the linker comprises a polynucleotide, polyethylene glycol, polysaccharide, or polypeptide.

9. The method according to claim 1 , wherein the first analyte and the second analyte are detected based on ion flow through the nanopore that is measured via an electrical means.

10. The method according to claim 1 , wherein the nanopore is a protein nanopore.

11. The method according to claim 10 , wherein the protein nanopore is derived from Msp or α-hemolysin (α-HL).

12. The method according to claim 1 , wherein the nanopore comprises a molecular adaptor that mediates interaction of the analyte with the nanopore.

13. The method according to claim 1 , wherein the nanopore is coupled to a polynucleotide binding protein.

14. The method according to claim 13 , wherein the polynucleotide binding protein is an exonuclease or a polymerase.

15. The method according to claim 1 , wherein the first analyte and the second analyte are detected based on ion flow through the nanopore that is measured by measuring a current passing through the nanopore.

16. The method according to claim 1 , wherein the tethering group comprises a polypeptide.

17. The method according to claim 1 , wherein the analyte is present in the solution of (b) at a concentration of less than 100 pM.

18. The method according to claim 1 , wherein the analyte is present in the solution of (b) at a concentration of about 0.001 pM to about 1 nM.

19. The method according to claim 1 , wherein rate of interaction of the molecules of the analyte with the nanopore is increased as compared to rate of interaction of molecules of the analyte with the nanopore in the absence of the tethering group.

20. The method according to claim 19 , wherein the rate of interaction of the molecules of the analyte is increased by at least three orders of magnitude.

21. The method according to claim 1 , wherein the effective concentration of the analyte at the nanopore is increased as compared to the concentration of the analyte in the solution of (b).

22. The method according to claim 1 , wherein a single nanopore providing an ion channel through the membrane is present in the membrane.

23. The method according to claim 1 , wherein the analyte is functionalized with the tethering group.

Assignments (2)
CHANGE OF NAME Recorded Jan 14, 2022
From: OXFORD NANOPORE TECHNOLOGIES LIMITED
To: OXFORD NANOPORE TECHNOLOGIES PLC
Reel/Frame 058737/0664 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2021
From: CLARKE, JAMES; WHITE, JAMES; MILTON, JOHN; BROWN, CLIVE
To: OXFORD NANOPORE TECHNOLOGIES LIMITED
Reel/Frame 054854/0685 →
Continuity (6)
Continuation 16428845 · May 31, 2019
Continuation 16243118 · Jan 9, 2019
Continuation 14122573
Provisional Application 61599246 · Feb 15, 2012
Provisional Application 61490860 · May 27, 2011
Related Publication 20210087623A1 · Mar 25, 2021
Cited By (2)
US 12,473,595 US 12,571,035